Featured Research

from universities, journals, and other organizations

Viral DNA In Bacterial Genome Could Hold Key To Novel Cystic Fibrosis Treatments

Date:
December 2, 2008
Source:
Cold Spring Harbor Laboratory
Summary:
The bacterium Pseudomonas aeruginosa is well known for its environmental versatility, ability to cause infection in humans, and antibiotic resistance. P. aeruginosa is the most common cause of lung infections in cystic fibrosis patients. Researchers have now used genomic techniques to study a particularly virulent strain of P. aeruginosa, uncovering genetic clues to its success that will aid in the design of novel therapeutic strategies.

The bacterium Pseudomonas aeruginosa is well known for its environmental versatility, ability to cause infection in humans, and its capacity to resist antibiotics. P. aeruginosa is the most common cause of persistent and fatal lung infections in cystic fibrosis patients. In a study published online in Genome Research, researchers have used genomic techniques to study a particularly virulent strain of P. aeruginosa, uncovering genetic clues to its success that will aid in the design of novel therapeutic strategies.

Related Articles


The Liverpool Epidemic Strain, the most common strain of P. aeruginosa infecting cystic fibrosis patients in the United Kingdom, is characterized by its particular aggressiveness and virulence. Though approximately 90% of the P. aeruginosa genome is shared between different strains, a team of scientist led by Dr. Craig Winstanley of the University of Liverpool set out to investigate the unique genomic features of the Liverpool strain.

"We used genome sequencing to reveal the secrets of the other 10% of the genome, which is likely to include genes contributing to the success of this particular strain," said Winstanley.

The research group found that many of the genes specific to the Liverpool Epidemic Strain are positioned in clusters, some of which are prophages. A prophage is a set of viral genes that became integrated into the DNA of bacteria infected by a bacterial virus. They then engineered mutations in prophages of the Liverpool strain and tested the pathogenicity of the mutant bacteria in a rat model of chronic lung infection. "We have shown that mutations within these novel prophages and genomic islands can prevent the strain from establishing infections," Winstanley described. "This indicates that bacterial viruses may contribute to the ability of bacterial pathogens to adapt to specific environments and to the emergence of particularly successful epidemic bacterial strains."

Winstanley also explained that this work is especially important in light of the nature of P. aeruginosa lung infections that afflict cystic fibrosis patients. Once an infection has been established, antibiotic therapy is unable to eradicate the bacteria from the lungs. Since antibiotics can be of limited use, the genomic properties of the Liverpool Epidemic Strain characterized in this study will aid in the development of novel strategies for circumventing ineffective antibiotic treatments by preventing infection altogether.

Scientists from the University of Liverpool (Liverpool, UK), Simon Fraser University (Burnaby, BC), Laval University (Quebec City, QC), The Wellcome Trust Sanger Institute (Hinxton, UK), and the University of British Columbia (Vancouver, BC) contributed to this study.

This work was supported by the Wellcome Trust, the Canadian Institutes of Health Research, the Canadian Cystic Fibrosis Foundation, the US Cystic Fibrosis Foundation, the Michael Smith Foundation for Health Research, the Big Lottery Fund, and the UK Cystic Fibrosis Trust.


Story Source:

The above story is based on materials provided by Cold Spring Harbor Laboratory. Note: Materials may be edited for content and length.


Journal Reference:

  1. Winstanley et al. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Research, 2008; DOI: 10.1101/gr.086082.108

Cite This Page:

Cold Spring Harbor Laboratory. "Viral DNA In Bacterial Genome Could Hold Key To Novel Cystic Fibrosis Treatments." ScienceDaily. ScienceDaily, 2 December 2008. <www.sciencedaily.com/releases/2008/12/081201195939.htm>.
Cold Spring Harbor Laboratory. (2008, December 2). Viral DNA In Bacterial Genome Could Hold Key To Novel Cystic Fibrosis Treatments. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2008/12/081201195939.htm
Cold Spring Harbor Laboratory. "Viral DNA In Bacterial Genome Could Hold Key To Novel Cystic Fibrosis Treatments." ScienceDaily. www.sciencedaily.com/releases/2008/12/081201195939.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins